Welcome to our dedicated page for Curaleaf Hldgs news (Ticker: CURLF), a resource for investors and traders seeking the latest updates and insights on Curaleaf Hldgs stock.
Curaleaf Holdings, Inc. (CURLF) is a prominent international provider of consumer cannabis products, known for its mission to enhance lives by sharing and celebrating the power of the plant. It operates under various brands like Curaleaf, Select, Grassroots, JAMS, Find, and Zero Proof in the medical and adult-use markets. With operations in over 15 countries globally, Curaleaf focuses on quality, expertise, and accessibility in the cannabis industry.
Recently, Curaleaf announced a strategic acquisition of Northern Green Canada, a licensed Canadian cannabis producer with a focus on international market expansion. This move aligns with Curaleaf's vision of becoming a global cannabis company with a strong presence in North America, Europe, and Australasia. The acquisition of NGC provides Curaleaf with EU-GMP certification, enabling the company to strengthen its supply chain, improve margins, and extend its global footprint.
Under the leadership of Boris Jordan, Executive Chairman, and Matt Darin, CEO, Curaleaf continues to drive growth and innovation within the cannabis space. The company's commitment to delivering high-quality products and patient access remains a top priority in evolving markets and regulatory environments.
Curaleaf Holdings held its annual and special meeting of shareholders on September 9, 2021, where nine directors were elected, including Boris Jordan and Joseph Lusardi. The shareholders reappointed Antares Professional Corporation as the Company's auditor and approved an amendment to extend the dual-class share structure. The amendment allows for continued multiple voting shares until specific conditions are met, such as a transfer of shares by Mr. Jordan. The Company plans to file an alteration notice on September 10, 2021.
Curaleaf Holdings announced participation in several investor community conferences throughout September 2021. Notable events include the Beacon Securities Virtual Cannabis Conference on September 9, featuring Joseph Lusardi, and the Needham 2nd Virtual Cannabis Conference on September 14, with CEO Joe Bayern. Additionally, Executive Chairman Boris Jordan will participate in the BTIG Inaugural Cannabis Conference on September 29. Curaleaf is a leading cannabis provider, operating in 23 states with over 109 dispensaries and active in the European market.
Curaleaf Holdings expands its presence with the opening of Curaleaf Bordentown, its 109th dispensary nationwide and third in New Jersey. The new 9,546 square foot location aims to serve the growing local market, especially as adult-use cannabis regulations are anticipated soon. Additionally, the popular Select brand launches in New Jersey, increasing its reach to 19 states. Curaleaf plans to add over 200 jobs and has committed to community engagement through donations and volunteer work.
Curaleaf Holdings reported strong financial results for Q2 2021, showing revenue of $312 million, a 166% year-over-year increase. Adjusted EBITDA reached $84 million, reflecting a 201% growth compared to the previous year. The gross margin improved to 49.6%, attributed to higher yields and operational efficiencies. Despite a net loss of $7.2 million, down from $17.2 million in Q1, the company completed the acquisition of EMMAC, enhancing its European presence. Curaleaf aims to leverage market opportunities with expanded adult-use markets in the U.S.
Curaleaf Holdings, Inc. (CURA/CURLF), a leading cannabis provider, announced that Executive Chairman Boris Jordan will present at the Canaccord Genuity 41st Annual Growth Conference on August 10, 2021, at 9:00 am ET. The management team will also hold investor meetings during this event. Curaleaf operates in 23 states with 108 dispensaries and is known for its high-quality cannabis products, aiming to enhance consumer confidence.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) has opened its 108th dispensary, located in Wells, Maine, marking its fifth location in the state. The new store will cater to medical cannabis patients, providing high-quality products and services, including curbside pick-up. The location complies with Maine's reciprocity laws, allowing out-of-state patients to access services. To celebrate the opening, Curaleaf is offering discounts and free delivery from July 23-25, as well as donating $5,000 to a local veterans' organization.
Curaleaf launches the B Noble brand to support social equity in cannabis, particularly highlighting the story of Bernard Noble, wrongfully imprisoned for cannabis possession. The brand, founded by Fab 5 Freddy, aims to raise awareness and funding for those impacted by harsh drug laws. It will release pre-roll products in Massachusetts and Maryland, donating 10% of proceeds to local organizations aiding those affected by the War on Drugs. This initiative aligns with Curaleaf's Rooted in Good program, promoting diversity and equity in the cannabis industry.
Curaleaf Holdings (CSE: CURA / OTCQX: CURLF) has appointed Ranjan Kalia as Chief Financial Officer, effective July 19, 2021, succeeding Michael Carlotti, who stepped down for medical reasons. Kalia brings over 30 years of experience in finance from companies like Virtusa Corp and EMC Corporation. Joseph Bayern, CEO, expressed optimism about Kalia's role in fueling the company's growth. Curaleaf operates 107 dispensaries across 23 states and is the largest vertically integrated cannabis company in Europe, underlining its commitment to strong financial performance.
Curaleaf Holdings has announced it will release its financial results for the second quarter ending June 30, 2021, on August 9, 2021, after market close. Management will hold a conference call and audio webcast at 5:00 p.m. ET that same day, featuring key operational highlights. Interested parties can join via phone or through a webcast. Curaleaf is a leading cannabis provider operating in 23 U.S. states and is the largest vertically integrated cannabis company in Europe.
Curaleaf International has formed a strategic partnership with Zambon GmbH, aiming to provide medical cannabis treatments in Germany, particularly for neurological therapies. The initial treatment is set to launch in Summer 2021. This partnership highlights Curaleaf's commitment to integrating pharmaceutical expertise with cannabis research. Germany's medical cannabis market is projected to reach USD 2.1 billion by 2025, making it a significant opportunity for growth. Both companies seek to enhance the quality of life for patients with chronic neurological conditions.
FAQ
What is the current stock price of Curaleaf Hldgs (CURLF)?
What is the market cap of Curaleaf Hldgs (CURLF)?
What is Curaleaf Holdings, Inc. known for?
Who are the key leaders at Curaleaf?
What recent acquisition has Curaleaf made?
Where does Curaleaf operate?
